Perceptive Advisors LLC
- SEC CIK
- 0001224962
- Latest filing
- Aug 14, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 102
- +10 vs. Q1 2026
- Portfolio value
- $6.44B
- +$1.38B (+27.2%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SYRESpyre Therapeutics, Inc. | COM NEW | 4,319,496 | $383.5M | 6.0% | +536,271+14.2% | Added | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 2,035,986 | $681.6M | 10.6% | 00.0% | Unchanged | History |
Options (6)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| MRNAModerna, Inc. | Stock | $70.0M | – |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $47.5M | – |
| CAPRCapricor Therapeutics, Inc. | COM NEW | $12.0M | $24.1M |
| EYPTEyePoint, Inc. | COM NEW | $28.6M | – |
| SLSSELLAS Life Sciences Group, Inc. | COM NEW | $22.1M | – |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | $16.9M | – |
Sold out since Q1 2026 (11)
Positions held at the end of Q1 2026 that are gone from this filing.
| Security | Class | Shares in Q1 2026 | Value in Q1 2026 | % of portfolio in Q1 2026 | History |
|---|---|---|---|---|---|
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 5,258,903 | $208.9M | 4.1% | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 1,755,799 | $37.6M | 0.7% | History |
| DRUGBright Minds Biosciences Inc. | COM NEW | 377,544 | $27.5M | 0.5% | History |
| BLTEBelite Bio, Inc | SPONSORED ADS | 151,979 | $24.2M | 0.5% | History |
| EVMNEvommune, Inc. | COM SHS | 448,350 | $10.3M | 0.2% | History |
| NMRANeumora Therapeutics, Inc. | COM | 5,104,097 | $9.95M | 0.2% | History |
| NBIXNeurocrine Biosciences Inc | Stock | 65,050 | $8.57M | 0.2% | History |
| IRDOpus Genetics, Inc. | COM | 1,835,842 | $8.35M | 0.2% | History |
| IKTInhibikase Therapeutics, Inc. | COM NEW | 2,315,000 | $3.89M | 0.1% | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 80,956 | $3.26M | 0.1% | History |
| PTNPalatin Technologies Inc | COM NEW | 61,945 | $1.08M | <0.1% | History |